Immunology
Individualized follow-up of COVID-19 vaccine for some HIV patients
Immune response protein is involved in embryonic development
A step closer to personalising multiple sclerosis treatment
Discovered a new mechanism against Epstein-Barr virus infection
Antibodies against SARS-CoV-2 remain stable seven months after the infection
Immunity anniversary: antibodies against SARS-CoV-2 remain one year after infection
Launched a clinical trial to prevent the side effects of COVID-19
SARS-Cov-2 antibodies detected three months after the infection
Drugs and antibodies: the strategies of two IMIM groups to block SARS-CoV-2
The antiviral drug remdesivir reduces the time to recovery in COVID-19 patients
